Since AR is a favorable prognostic indicator, and its action in breast epithelium generally leads to inhibition of cell growth [95–97], loss of NcoA4 and/or AR in the presence of Her2/neu could represent more aggressive subtypes of invasive breast cancer. This evidence concerns the gene ERBB2 and invasive breast carcinoma.